Cargando…

Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease

Since the first description of Parkinson's disease (PD) nearly two centuries ago, a number of studies have revealed the clinical symptoms, pathology, and therapeutic approaches to overcome this intractable neurodegenerative disease. 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-hydro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Kyota, Nakabeppu, Yusaku, Noda, Mami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109337/ https://www.ncbi.nlm.nih.gov/pubmed/21687749 http://dx.doi.org/10.4061/2011/307875

Ejemplares similares

Therapeutic Approach to Neurodegenerative Diseases by Medical Gases: Focusing on Redox Signaling and Related Antioxidant Enzymes
por: Fujita, Kyota, et al.
Publicado: (2012)

Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease
por: Fujita, Kyota, et al.
Publicado: (2009)

Oral ‘hydrogen water' induces neuroprotective ghrelin secretion in mice
por: Matsumoto, Akio, et al.
Publicado: (2013)

Cellular Levels of 8-Oxoguanine in either DNA or the Nucleotide Pool Play Pivotal Roles in Carcinogenesis and Survival of Cancer Cells
por: Nakabeppu, Yusaku
Publicado: (2014)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Oxidative Stress and Microglial Response in Retinitis Pigmentosa
por: Murakami, Yusuke, et al.
Publicado: (2020)

Nucleotides function as endogenous chemical sensors for oxidative stress signaling
por: Ihara, Hideshi, et al.
Publicado: (2011)

Classic and New Animal Models of Parkinson's Disease
por: Blesa, Javier, et al.
Publicado: (2012)

Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease
por: Ham, Sangwoo, et al.
Publicado: (2019)

Sex Differences in Dendritic Spine Formation in the Hippocampus and Animal Behaviors in a Mouse Model of Hyperthyroidism
por: Niiyama, Tetsushi, et al.
Publicado: (2020)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Animal Models for Parkinson’s Disease Research: Trends in the 2000s
por: Kin, Kyohei, et al.
Publicado: (2019)

Parkinson’s Disease: Exploring Different Animal Model Systems
por: Khan, Engila, et al.
Publicado: (2023)

Homeostatic and endocrine responses as the basis for systemic therapy with medical gases: ozone, xenon and molecular hydrogen
por: Nazarov, Eugene Iv., et al.
Publicado: (2021)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Correction: PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes, suppressing or increasing apoptosis under oxidative conditions
por: Ishii, Takashi, et al.
Publicado: (2021)

Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis
por: Seike, Toshihiro, et al.
Publicado: (2010)

Animal Model for Lower Urinary Tract Dysfunction in Parkinson’s Disease
por: Kitta, Takeya, et al.
Publicado: (2020)

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
por: Prasad, E. Maruthi, et al.
Publicado: (2020)

Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review
por: Salehpour, Farzad, et al.
Publicado: (2020)

Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
por: Muksuris, Katherine, et al.
Publicado: (2023)

Animal Models of Autosomal Recessive Parkinsonism
por: Bastioli, Guendalina, et al.
Publicado: (2021)

Structure of the mammalian adenine DNA glycosylase MUTYH: insights into the base excision repair pathway and cancer
por: Nakamura, Teruya, et al.
Publicado: (2021)

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
por: Deng, Isaac, et al.
Publicado: (2020)

Animal Models of Parkinson's Disease 2012
por: Imai, Yuzuru, et al.
Publicado: (2012)

Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
por: Zeng, Xian-Si, et al.
Publicado: (2018)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Transcriptome Analysis in Hippocampus of Rats Prenatally Exposed to Valproic Acid and Effects of Intranasal Treatment of Oxytocin
por: Matsuo, Kazuya, et al.
Publicado: (2022)

Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
por: Dovonou, Axelle, et al.
Publicado: (2023)

Experimental Animal Models of Pancreatic Carcinogenesis for Prevention Studies and Their Relevance to Human Disease
por: Takahashi, Mami, et al.
Publicado: (2011)

Limited therapeutic potential of astrocyte elevated gene-1 transduction in an animal model of Parkinson's disease
por: Leem, Eunju, et al.
Publicado: (2020)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fhn78ajonlcd2jhbdqnmv9egme